Abpro
Developing antibody therapies to improve the lives of patients facing severe and life-threatening diseases.
abpro.co · Biotechnology Research · Woburn, Massachusetts · Founded 2007
We're a public biotech company (Nasdaq: ABP) leveraging our proprietary DiversImmune® and MultiMab platforms to advance next-generation antibody therapeutics for immuno-oncology and ophthalmology. Collaborating with global pharmaceutical and research partners, we're advancing a robust pipeline of innovative treatments. For more information, please visit https://abpro.co/
No validated artifacts for this company yet.